Drug intelligence / Profile preview

diphenhydramine + acetaminophen

Development stage
Unknown
Lead developer
Johnson & Johnson
Modality
Small Molecules
Administration
Oral
01

Overview

Diphenhydramine + acetaminophen is an oral combination drug containing two active ingredients: - **Acetaminophen** is a non-opioid analgesic and antipyretic that reduces fever and relieves mild to moderate pain by inhibiting prostaglandin synthesis in the central nervous system. - **Diphenhydramine** is a first-generation antihistamine that acts as an antagonist at histamine H1 receptors. It provides relief from allergy symptoms and also has sedative properties due to its ability to cross the blood-brain barrier. This combination is primarily used for short-term management of occasional insomnia associated with minor aches and pains (such as headache, back pain, joint or muscle pain), as well as for relief of cold or allergy symptoms like runny nose or sneezing when accompanied by discomfort. It should not be used solely for sleep problems without pain[1][2][3][5].

Brand names
Tylenol PMMidol PMPercogesic Original StrengthLegatrin PMHeadache Relief PMTheraflu Multi-Symptom Severe ColdTylenol Cold NighttimeTylenol PM Extra StrengthTylenol Sore Throat Nighttime
Other names
acetaminophen and diphenhydramine
02

Targets

M1 (Muscarinic acetylcholine receptor M1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on diphenhydramine + acetaminophen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diphenhydramine + acetaminophen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call